Status:

COMPLETED

MINDFUL-OBOT: Effect of Mindfulness on Opioid Use and Anxiety During Primary Care Buprenorphine Treatment

Lead Sponsor:

Cambridge Health Alliance

Collaborating Sponsors:

National Center for Complementary and Integrative Health (NCCIH)

Conditions:

Opioid-use Disorder

Anxiety

Eligibility:

All Genders

18+ years

Phase:

NA

Brief Summary

The goal of this pilot study is to test the Mindful Recovery OBOT Care Continuum (M-ROCC) model in primary care office-based opioid treatment (OBOT). M-ROCC features integration of evidence-based mind...

Detailed Description

The primary objective of this study is to conduct a single-arm pilot study in order to refine a Mindfulness-Based Intervention for the Opioid Use Disorder (OUD) treatment in primary care, called the M...

Eligibility Criteria

Inclusion

  • 18 years or older
  • Current CHA patient with a CHA primary care provider
  • Diagnosis of opioid use disorder prescribed buprenorphine/naloxone
  • Sufficient English fluency to understand procedures and questionnaires
  • \<90 days of complete abstinence from illicit opioids, cocaine, benzodiazepines, AND alcohol (excluding cannabis/nicotine)
  • Ability to provide informed consent.

Exclusion

  • Psychosis
  • Mania
  • Thought disorder
  • Schizophrenia or Schizoaffective disorder
  • Acute suicidality with plan
  • Cognitive inability as demonstrated by Montreal Cognitive Assessment (MOCA) \<24 OR the inability to complete consent quiz and baseline assessments.
  • Current participation in another CHA research study
  • Expected hospitalization in next 6 months, including second and third trimester pregnancy at screening.

Key Trial Info

Start Date :

December 11 2018

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

February 3 2020

Estimated Enrollment :

25 Patients enrolled

Trial Details

Trial ID

NCT03798431

Start Date

December 11 2018

End Date

February 3 2020

Last Update

March 14 2025

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Cambridge Health Alliance

Somerville, Massachusetts, United States, 02143